Skip to main content

Table 2 Characteristics of participants’ Clostridioides difficile infection (CDI)

From: Perception of quality of life in people experiencing or having experienced a Clostridioides difficile infection: a US population survey

 Current CDI (n = 115)Past CDI (n = 235)
Last CDI occurrence date (Past CDI)
CDI occurrence start date (Current CDI)
 In the last week8 (7%)1 (0.4%)
 Between 1 and 2 week(s) ago7 (6.1%)4 (1.7%)
 Between 2 and 4 weeks ago17 (14.8%)2 (0.9%)
 Between 1 and 3 months ago30 (26.1%)20 (1.7%)
 Between 3 and 6 months ago20 (17.4%)24 (10.2%)
 Between 6 and 12 months ago16 (13.9%)38 (16.2%)
 More than 12 months ago17 (14.8%)146 (62.1%)
CDI treatments
 Subjects remembering their CDI treatment /currently treated for CDI97 (84.3%)229 (97.4%)
 Metronidazole48 (49.5%)144 (62.9%)
 Vancomycin53 (54.6%)187 (81.7%)
 Fidaxomicin17 (17.5%)60 (26.2%)
 Fecal microbiota transplant10 (10.3%)66 (28.8%)
 Probiotics38 (39.2%)151 (65.9%)
 Other treatment4 (4.1%)22 (9.6%)
Surgery
 GI surgery due to CDIN/A11 (4.7%)
Recurrences
 Subjects who have experienced at least one recurrenceN/A105 (44.7%)
\